Sign in

CIK 0001746473

  • Non-accelerated filer
  • Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474272481
Phone
+1 650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-06-16 Shah Smital Director Grant or award · Stock Option (right to buy) +15,000 15,000
2022-01-26 Ouimette Mike General Counsel & Corp. Sec'y Grant or award · Stock Option (right to buy) +87,000 87,000
2022-01-26 Cummings Keith Lamont Chief Financial Officer Grant or award · Stock Option (right to buy) +124,000 124,000
2022-01-26 Hull Hans Chief Business Officer Grant or award · Stock Option (right to buy) +112,500 112,500
2022-01-26 Lefebvre Eric Chief Medical Officer Grant or award · Stock Option (right to buy) +140,000 140,000
2022-01-26 Coulie Bernard President and CEO Grant or award · Stock Option (right to buy) +440,000 440,000
2021-09-03 Cummings Keith Lamont Chief Financial Officer Exercise or conversion +20,000 $2.08 $42K 67,621
2021-09-03 Cummings Keith Lamont Chief Financial Officer Exercise or conversion · Stock Option (right to buy) −20,000 150,097
2021-06-29 PYOTT DAVID E I Director Grant or award · Stock Option (right to buy) +13,286 13,286
2021-06-29 Shah Smital Director Grant or award · Stock Option (right to buy) +13,286 13,286
2021-06-29 PYOTT DAVID E I Director Grant or award · Stock Option (right to buy) +13,286 13,286
2021-06-29 Huh Hoyoung Director Grant or award · Stock Option (right to buy) +13,286 13,286
2021-06-29 HOMCY CHARLES J Director Grant or award · Stock Option (right to buy) +13,286 13,286
2021-06-29 Exter Neil Director Grant or award · Stock Option (right to buy) +13,286 13,286
2021-06-29 Curnutte John T Director Grant or award · Stock Option (right to buy) +13,286 13,286
2021-06-29 CROWELL GAYLE A Director Grant or award · Stock Option (right to buy) +13,286 13,286
2021-06-29 Bruhn Suzanne Louise Director Grant or award · Stock Option (right to buy) +13,286 13,286
2021-06-18 Lefebvre Eric Chief Medical Officer Sale −8,750 $28.62 $250K 140,830
2021-06-18 Lefebvre Eric Chief Medical Officer Sale −3,728 $29.43 $110K 137,102
2021-06-18 Lefebvre Eric Chief Medical Officer Sale −22 $30.23 $665 137,080

Page 15 of 19 · 379 trades